3M TAVR Study Protocol The Multidisciplinary, Multimodality, but Minimalist (3M)Approach to Transfemoral Transcatheter Aortic Valve Replacement (TAVR) Study
Observational study for patients with severe symptomatic aortic stenosis using the Transfemoral Transcatheter Aortic Valve Replacement
Sponsor: BC Centre for Improved Cardiovascular Health
Enrolling: Male and Female Patients
IRB Number: AAAP8663
U.S. Govt. ID: NCT02287662
Contact: Lauren Privitera: 212-342-3488 / lp2183@cumc.columbia.edu
Additional Study Information: This observational study is designed to collect and evaluate information describing patients undergoingTAVR using two different clinical pathways. Information describing both groups will be analyzed tocompare safety and clinical outcomes. A quality of life and cost analysis will be performed to comparepatients in the Vancouver 3M Clinical Pathway with those undergoing Standard TAVR.
This study is closed
Investigator
Tamim Nazif, MD
Do You Qualify?
Do you have severe symptomatic aortic stenosis? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Lauren Privitera
lp2183@cumc.columbia.edu
212-342-3488
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE